Knowledge

bioMérieux, a world leader in in vitro diagnostics, continues its long-standing collaboration with the food safety industry to provide a comprehensive suite of solutions and services for infant formula manufacturers and ingredient suppliers.

bioMérieux has entered into a strategic research collaboration with the US Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens.

Current quality control test kits for the brewing industry are designed to detect potential spoilers in the finished product, not in the yeast slurries themselves. GENE-UP® BREWPRO™ YS was built to analyze yeast in its cell-dense raw material state and is calibrated against specialized targets tailor-made for yeast slurries.

bioMérieux has announced the lease signing of a new, 32,000 sq. ft. state-of-the-art molecular innovation center at the Navy Yard in Philadelphia.

The addition of these offerings strengthens the company’s comprehensive portfolio of cannabis microbial testing solutions to provide enhanced control of the cannabis cultivation process risk, creating efficiencies and boosting the bottom line from seed to sale.

bioMérieux, a world leader in in vitro diagnostics, announces the availability of GENE-UP® ENVIROPRO™, the only assay of its kind to simultaneously detect both Salmonella and Listeria from environmental swabbing, including PCR confirmation.

Validated by Wineries to Verify Final Filtration Prior to Bottling On-Site, Solution is Now Available with bioMérieux’s Comprehensive End-To-End Wine Quality Product Portfolio.

Company’s True Non-Enrichment Quantification Diagnostic Is The Standard-Setting Guideline for Salmonella Food-Safety Testing in the U.S.

Company is Changing the Game of Food Safety and Quality by Bringing the Best Minds and the Best Science Together to Provide Compliant, Impactful Solutions for the Industry.

Its Predictive Diagnostic Innovation Center and Invisible Sentinel Team announce the GENE-UP® PRO ACB to prevent flavor imbalance in one step instead of two.

For the second year running, bioMérieux and Mérieux NutriSciences have joined forces to better understand consumer perceptions around food safety on an international scale.

Following a Memorandum of Understanding, signed in 2016, for a bilateral scientific collaboration on Food Safety between FSSAI (Food Safety & Standards Authority of India) and ANSES (French Agency for Safety of Food, Environment and Occupational Health, France), and along with the support from the Embassy of France in India, a 2nd “Hands-on Training Program on Advanced Microbiological Techniques” was conducted.

“Take Off the Pump Handle”: BioFire CEO Randy Rasmussen on Meeting the New Challenges of Infectious Disease. Discover his keynote speech at the 2018 bioMérieux “Night at the Museum” event held in Salt Lake City, Utah on July 9th, 2018.

bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) develops, manufactures and markets innovative and user-friendly molecular diagnostic tools for the rapid, accurate and reliable detection of pathogens and spoilage organisms in food and beverage.

Chicago (IL, USA), Marcy l’Étoile (France), June 7th, 2019 – For this inaugural World Food Safety Day, Mérieux NutriSciences and bioMérieux conducted an international consumer survey to better understand consumer perception and behaviors towards food safety in four countries: the United States, China, France and India.

Predictive Diagnostics uses traditional core microbiology solutions alongside data science, sequencing applications and predictive modeling to help move food producers from being reactive by detecting and responding to safety and quality issues, to being proactive by predicting and preventing them.